BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 35714308)

  • 1. TET2-mutant clonal hematopoiesis and risk of gout.
    Agrawal M; Niroula A; Cunin P; McConkey M; Shkolnik V; Kim PG; Wong WJ; Weeks LD; Lin AE; Miller PG; Gibson CJ; Sekar A; Schaefer IM; Neuberg D; Stone RM; Bick AG; Uddin MM; Griffin GK; Jaiswal S; Natarajan P; Nigrovic PA; Rao DA; Ebert BL
    Blood; 2022 Sep; 140(10):1094-1103. PubMed ID: 35714308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal Hematopoiesis of Indeterminate Potential With Loss of
    Lin AE; Bapat AC; Xiao L; Niroula A; Ye J; Wong WJ; Agrawal M; Farady CJ; Boettcher A; Hergott CB; McConkey M; Flores-Bringas P; Shkolnik V; Bick AG; Milan D; Natarajan P; Libby P; Ellinor PT; Ebert BL
    Circulation; 2024 Apr; 149(18):1419-1434. PubMed ID: 38357791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower Temperatures Exacerbate NLRP3 Inflammasome Activation by Promoting Monosodium Urate Crystallization, Causing Gout.
    Ahn H; Lee G; Lee GS
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B(4) in a murine model of gout.
    Amaral FA; Costa VV; Tavares LD; Sachs D; Coelho FM; Fagundes CT; Soriani FM; Silveira TN; Cunha LD; Zamboni DS; Quesniaux V; Peres RS; Cunha TM; Cunha FQ; Ryffel B; Souza DG; Teixeira MM
    Arthritis Rheum; 2012 Feb; 64(2):474-84. PubMed ID: 21952942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A wild rice-derived peptide R14 ameliorates monosodium urate crystals-induced IL-1β secretion through inhibition of NF-κB signaling and NLRP3 inflammasome activation.
    Charoenwutthikun S; Chanjitwiriya K; Roytrakul S; Kunthalert D
    PeerJ; 2023; 11():e15295. PubMed ID: 37197585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretion of IL-1β From Monocytes in Gout Is Redox Independent.
    Alberts BM; Bruce C; Basnayake K; Ghezzi P; Davies KA; Mullen LM
    Front Immunol; 2019; 10():70. PubMed ID: 30761138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decoy Receptor 3 Inhibits Monosodium Urate-Induced NLRP3 Inflammasome Activation
    Pan YG; Huang MT; Sekar P; Huang DY; Lin WW; Hsieh SL
    Front Immunol; 2021; 12():638676. PubMed ID: 33746978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome.
    Sano S; Oshima K; Wang Y; MacLauchlan S; Katanasaka Y; Sano M; Zuriaga MA; Yoshiyama M; Goukassian D; Cooper MA; Fuster JJ; Walsh K
    J Am Coll Cardiol; 2018 Feb; 71(8):875-886. PubMed ID: 29471939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Gout-associated MSU crystals-induced NLRP3 inflammasome activation by procyanidin B2: targeting IL-1β and Cathepsin B in macrophages.
    Qiao CY; Li Y; Shang Y; Jiang M; Liu J; Zhan ZY; Ye H; Lin YC; Jiao JY; Sun RH; Zhang ZH; Piao MH; Wu YL; Nan JX; Lian LH
    Inflammopharmacology; 2020 Dec; 28(6):1481-1493. PubMed ID: 33006110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigallocatechin-3-Gallate Prevents Acute Gout by Suppressing NLRP3 Inflammasome Activation and Mitochondrial DNA Synthesis.
    Lee HE; Yang G; Park YB; Kang HC; Cho YY; Lee HS; Lee JY
    Molecules; 2019 Jun; 24(11):. PubMed ID: 31174271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monosodium urate crystals alter the circadian clock in macrophages leading to loss of NLRP3 inflammasome repression: Implications for timing of the gout flare.
    Popov D; Jain L; Alhilali M; Dalbeth N; Poulsen RC
    FASEB J; 2023 Jun; 37(6):e22940. PubMed ID: 37243314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Berberine on Activation of TLR4-NFκB Signaling Pathway and NLRP3 Inflammasome in Patients with Gout.
    Dang WT; Xu D; Zhou JG
    Chin J Integr Med; 2023 Jan; 29(1):10-18. PubMed ID: 36125615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-Like Receptor 9 Is Involved in NLRP3 Inflammasome Activation and IL-1β Production Through Monosodium Urate-Induced Mitochondrial DNA.
    Kim SK; Park KY; Choe JY
    Inflammation; 2020 Dec; 43(6):2301-2311. PubMed ID: 32700178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human proteoglycan-4 reduces phagocytosis of urate crystals and downstream nuclear factor kappa B and inflammasome activation and production of cytokines and chemokines in human and murine macrophages.
    Qadri M; Jay GD; Zhang LX; Wong W; Reginato AM; Sun C; Schmidt TA; Elsaid KA
    Arthritis Res Ther; 2018 Aug; 20(1):192. PubMed ID: 30157934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precipitation of Soluble Uric Acid Is Necessary for
    Alberts BM; Barber JS; Sacre SM; Davies KA; Ghezzi P; Mullen LM
    J Rheumatol; 2019 Sep; 46(9):1141-1150. PubMed ID: 30824640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial Properties of Phytochemicals on NLRP3 Inflammasome-Mediated Gout and Complication.
    Jhang JJ; Lin JH; Yen GC
    J Agric Food Chem; 2018 Jan; 66(4):765-772. PubMed ID: 29293001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gout-associated monosodium urate crystal-induced necrosis is independent of NLRP3 activity but can be suppressed by combined inhibitors for multiple signaling pathways.
    Zhong CS; Zeng B; Qiu JH; Xu LH; Zhong MY; Huang YT; Xu R; Liu SY; Zha QB; Hu B; Ou-Yang DY; He XH
    Acta Pharmacol Sin; 2022 May; 43(5):1324-1336. PubMed ID: 34376811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRCC3-Mediated NLRP3 Deubiquitylation Promotes Inflammasome Activation and Atherosclerosis in
    Yalcinkaya M; Liu W; Thomas LA; Olszewska M; Xiao T; Abramowicz S; Papapetrou EP; Westerterp M; Wang N; Tabas I; Tall AR
    Circulation; 2023 Nov; 148(22):1764-1777. PubMed ID: 37781816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced interleukin-1β production of PBMCs from patients with gout after stimulation with Toll-like receptor-2 ligands and urate crystals.
    Mylona EE; Mouktaroudi M; Crisan TO; Makri S; Pistiki A; Georgitsi M; Savva A; Netea MG; van der Meer JW; Giamarellos-Bourboulis EJ; Joosten LA
    Arthritis Res Ther; 2012 Jul; 14(4):R158. PubMed ID: 22762240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-(2-(4-chlorophenyl)-1-((4-chlorophenyl)amino)ethyl)benzene-1, 3-diol is a potential agent for gout therapy as a dual inhibitor of XOD and NLRP3.
    Zhou M; Li S; Song L; Hu Q; Liu W
    Phytomedicine; 2018 Mar; 42():9-17. PubMed ID: 29655702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.